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Abstract 
Every year thousands of patients are diagnosed with a glioma, a type of malignant brain tumor. 
Physicians use MR brain images as a key tool in the diagnosis and treatment of these patients. Neural 
networks show great potential to aid physicians in the medical image analysis. This study investigates 
the use of varying amounts of synthetic brain T1-weighted (T1), post-contrast T1-weighted (T1Gd), T2-
weighted (T2), and T2 Fluid Attenuated Inversion Recovery (FLAIR) MR images created by a generative 
adversarial network to overcome the lack of annotated medical image data in training separate 2D U-
Nets to segment enhancing tumor, peritumoral edema, and necrosis (non-enhancing tumor core) 
regions on gliomas.  These synthetic MR images were assessed quantitively (SSIM=0.79) and 
qualitatively by a physician who found that the synthetic images seem stronger for delineation of 
structural boundaries but struggle more when gradient is significant, (e.g. edema signal in T2 
modalities). Multiple 2D U-Nets were trained with original BraTS data and differing subsets of a quarter, 
half, three-quarters, and all synthetic MR images. There was not an obvious correlation between the 
improvement of values of the metrics in separate validation dataset for each structure and amount of 
synthetic data added, there is a strong correlation between the amount of synthetic data added and the 
number of best overall validation metrics. Out of the twelve validation metrices, one validation metric 
was highest of any reported values when a quarter of synthetic data was used during training, three 
were the highest when half the synthetic data was used, four were highest when three-quarters of the 
synthetic data was added, and six were the highest when all synthetic images were used during training. 
In summary, this study showed ability to generate high quality synthetic Flair, T2, T1, and T1CE MR 
images using the GAN. Using the synthetic MR images showed encouraging results to improve the U-Net 
segmentation performance which has the potential to address the scarcity of readily available medical 
images.   
 
 
 
 
1.0 Introduction 
Approximately 121,000  [1] people in the US are diagnosed with a malignant brain tumor annually, and 
more than 13,000 of those being Glioblastoma (GBM) WHO grade IV tumors with an unacceptable 
median overall survival despite best available treatment of less than to 2 years. For primary brain 
tumors WHO grade II-IV there are no curative treatments and limited approved therapies. Current 
management of primary brain tumors has two standard benchmarks, tissue analysis for diagnosis and 
the longitudinal analysis of treatment response/ tumor stability through serial brain tumor imaging. In 
fact, the brain MRI in patients with GBM is used to stratify clinical trial options prior to initial surgery and 
to offer patients definitive cytoreduction surgery for malignant glioma or GBM when radiographic 
features are highly suggestive of a malignant tumor.  Therefore, advanced imaging methods to stratify 
patients into phenotypic, functional, molecular, and prognostic groups is highly sought after.  
 
Amongst, GBM researchers, clinicians, patients, and patient advocates there is hope that new advances 
as promised by molecular targeted therapies, advanced radiation techniques, evolving surgical 
technologies, and unforeseen innovation will result in improved patient outcomes. Central to all of these 
is radiographic imaging; both for diagnosis and longitudinal patient monitoring. Applications of deep 
machine learning in brain tumor imaging has the potential to transition from a subjective analysis to 
objective analysis and create a new set of tools to refine treatment options, improve care quality, and 
ultimately impact patient care. One critical limitation to achieving the success seen in non-medical 
imaging is the volume of data needed to power deep machine learning. One possible solution to 
overcoming the limited brain tumor imaging data available for analysis is to create synthetic brain tumor 
MR images. Herein, we evaluate the performance of image segmentation using U-Net by augmenting 
the data with generative adversarial networks (GAN).  Specifically, we investigate the accuracy of 
segmentation of whole tumor, enhancing tumor, and tumor core for glioma patients using T1-weighted 
(T1), post-contrast T1-weighted (T1Gd), T2-weighted (T2), and T2 Fluid Attenuated Inversion Recovery 
(FLAIR) images, and create an enhanced imaging data repository through creating synthetic brain tumor 
imaging.  
 
The 2D U-Net [2]is the model used to create these segmentations for this study. It was chosen as it 
outperforms other models, such as the sliding window convolutional network, and is used in similar 
studies due to its ability to retain spatial information. It is common knowledge that deep learning 
techniques are highly powerful when the amount of training samples is large. However, in the medical 
field, especially in clinical trials, where limited numbers of training samples are accessible, deep learning 
models are easily overfitting during training stage and perform poorly in prediction. [3] Besides, 
annotation of medical images requires clinicians to be well-trained and experienced and is generally 
expensive and time-consuming. 
 
Synthesizing new images as training samples provides a possible solution to overcome the challenge of 
limited number of annotated medical images. The original idea of synthesizing images indistinguishable 
from reality is inspired by the development of GANs. [4] Researchers then have leveraged GANs in a 
conditional setting which allows the model to deterministically control the generation of particular 
samples based on external information. [5-7] However, some researchers suggested that adversarial 
training might be unstable or even diverge, and introduced image per-pixel loss and perceptual loss. [8] 
In this paper, we proposed an Augmentation Network that was trained in a supervised fashion using 
paired brain maps and real patient MRI images and generated new training samples from manipulated 
brain maps.  
 
2.0 Methods 
2.1 Patient Population 
Data was obtained from the BraTS multimodal Brain Tumor Segmentation Challenge 2018. [9-12] 19 
different institutions provided a total of 210 patients for training and 66 patients for validation.  T1, 
T1CE, T2, and FLAIR MR images were provided for each patient. BraTS provided accurate delineation of 
enhancing tumor, peritumoral edema, and necrosis (non-enhancing tumor core) performed by one to 
four clinicians and approved by neuro-oncologists.  
 
2.2 Image Pre-Processing 
T1, T2, and FLAIR MRI were rigidly registered with the T1CE, resampled (1 × 1 × 1mm3), skull stripped, 
and normalized. The enhancing tumor, peritumoral edema, and necrosis (non-enhancing tumor core) 
regions are small compared to the total 3D MRI volumes (256×256×155) creating a data imbalance. To 
combat this problem, 64 slices image patches covering these regions were extracted. Data 
augmentation was done by flipping each slice left/right to decrease dependence on location as the brain 
exhibits marked symmetry across the sagittal plane. All 155 slices of each MRI 3D volume were 
segmented during validation.  
 
2.3 Generative Adversarial Neural Network  
To overcome the limitation imposed by limited volume of MR data, the deep learning model named as 
Augmentation Network was employed to create artificial MR images from real images by changing tumor 
size, location and orientation. The Augmentation Network works by creating two competing networks. 
The generator creates the MR images, while the discriminator judges the quality of the MR image created 
by the generator. If the discriminator decides the generator created image lacks the quality of real images 
used for training, the generator is penalized. This process repeats as the generator changes parameters 
until the image quality is passed by the generator. 
 
2.3.1 Architecture 
Our augmentation network consists of a generator (blue box in Figure 1) and two discriminators (red and 
yellow box in Figure 1). The generator is used to generate synthetic MRI images from brain maps which 
are derived from real MRI images. The brain map is composed with the segmentation of normal brain 
tissue and defined sub-regions of GBM (enhancing tumor, necrosis/non-enhancing tumor and edema). 
The segmentation of normal brain tissue is achieved by image thresholding (3/4, 1/2 and 1/4 of max pixel 
value). The discriminators are used to distinguish between synthetic images and real patient images. 
 
2.3.2 Generator 
The generator consists of several components Ci, each operates at a different resolution. The brain map 
(256 × 256) is down-sampled to provide segmentation layout at different resolutions (wi × hi, wi = hi). The 
first component C0 gets down-sampled brain map at the resolution of w0 = h0 = 4 as input and generates 
feature maps as output to the next component. For components C1 to Cn, feature maps from previous 
component are up-sampled at scale of 2 and are concatenated with brain map of the same resolution as 
input. Residual block is applied to generate feature maps as output. Convolution kernel size is 3×3, layer 
normalization[13] is applied, LReLU [14] is used as the activation function.  
 
2.3.3 Discriminator 
 (3) Two discriminators are used. The first one is a pre-trained VGG-19 convolutional neural network, [15] 
which won the first and second place in localization and classification in the Image Net Large Scale Visual 
Recognition Challenge (ILSVRC) 2014. It is used to calculate the perceptual loss (∑ 𝑝𝑖𝑖 ) and the image per-
pixel loss ℒ𝑖𝑚.  
ℒ𝑖𝑚 =  ∑ ∑ ||𝐼𝑟𝑒𝑎𝑙 − 𝐼𝑠𝑦𝑛𝑡ℎ𝑒𝑡𝑖𝑐||1𝑛𝑚                 (1)  
𝐼𝑟𝑒𝑎𝑙 represents for real patient MRI image, 𝐼𝑠𝑦𝑛𝑡ℎ𝑒𝑡𝑖𝑐 represents for synthetic MRI image from the 
generator. 
𝑝𝑖 =  ∑ ∑ ||𝜃𝑖𝑟𝑒𝑎𝑙 − 𝜃𝑖𝑠𝑦𝑛𝑡ℎ𝑒𝑡𝑖𝑐||1𝑛𝑚                   (2) 
𝑝𝑖  is the perceptual loss from layer i of VGG-19 Net. 𝜃𝑖𝑟𝑒𝑎𝑙 and 𝜃𝑖𝑠𝑦𝑛𝑡ℎ𝑒𝑡𝑖𝑐 are feature maps of patient MRI 
image and synthetic MRI images generated at layer i respectively. The second one is a patch GAN, which 
penalizes on image patches, the loss is given as ℒ𝑎𝑑𝑣 =  𝔼[𝐷(𝐼𝑟𝑒𝑎𝑙 , 𝐼𝑠𝑦𝑛𝑡ℎ𝑒𝑡𝑖𝑐)] + 𝔼[1 − 𝐷(𝐼𝑠𝑦𝑛𝑡ℎ𝑒𝑡𝑖𝑐)]. 
𝐷(∙) is the discriminator net. Total loss is computed as the weighted summation of each loss. 
The synthetic image is acquired by solve the following objective: 
𝑆∗ =  𝑎𝑟𝑔𝑚𝑖𝑛(𝔼[∑ 𝜆𝑖𝑝𝑖 ,
𝑛
𝑖=0 + 𝜆𝑖𝑚ℒ𝑖𝑚] + 𝜆ℒ𝑎𝑑𝑣)   (3) 
 
2.3.4 Training and generation of new training samples 
164 patients were randomly selected from BraTS18 dataset for training. For each MRI modality, an 
independent model was trained. 𝜆𝑖, 𝜆𝑖𝑚 and 𝜆 were adapted every 10 epochs to maintain balance among 
each loss. Total training epoch is 100 for each modality. Then the brain map was manipulated for different 
lesion location, shape or size. Generated images and manipulated brains maps were used as new training 
samples to train the new model. 
 Figure 1. Architecture of Augmentation Net. Generator is shown in blue box and discriminators in yellow 
and red boxes. 
 
2.4 U-Net 
T1, T2, and FLAIR MRI used for input for three individual U-Nets. Whole tumor (WT), enhancing tumor 
(ET), and tumor core (TC) each received their own U-Net. The U-Net followed Pelt et al.’s [16] 
recommendation of four scaling layers. The U-Net, designed by Ronneberger, et al. [2] maintains the 
spatial information while doubling features for each consecutive convolutional layer with batch 
normalization [12] and halving the number of features for each consecutive up-sampling layer. These 
layers combined to form a merged layer and soft dice (equation 4) was employed as the loss function. 
   
Dice Loss =
2∗<𝑦𝑡𝑟𝑢𝑒,𝑦𝑝𝑟𝑒𝑑>+𝑐
<𝑦𝑡𝑟𝑢𝑒,𝑦𝑡𝑟𝑢𝑒>+<𝑦𝑝𝑟𝑒𝑑,𝑦𝑝𝑟𝑒𝑑>+𝑐
                                         (4) 
ytrue is clinician’s contour, ypred is model’s output, and c (0.01) is a constant to avoid division-by-zero 
singularities.    
Each U-Net was able to produce the corresponding mask they were trained on creating a whole tumor 
model, an enhancing tumor model, and a tumor center model. To improve ET/TC accuracy, the intensity 
difference between T1CE and T1 was calculated on a pixel level in each slice and only ET/TC predictions 
within the whole tumor contour were accepted. The best model for each type of contour was chosen 
according to the validation loss within 100 epochs run on GPU (Titan XP, nVidia, Santa Clara, CA).   
 
2.5 Statistics 
The metrics used to evaluate the agreement between the created U-Net model and the given reference 
contours are the dice similarity coefficient (DSC), Hausdorff distance (HD), sensitivity, and specificity.  
Sensitivity (equation 5) is also known as a true positive, while specificity (equation 6) is known as a true 
negative. 
 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠+𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑎𝑙𝑠𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
                           (5) 
 
 𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠+𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑡𝑖𝑣𝑖𝑒𝑠
                           (6) 
 
The DSC (equation 7) gives statistic regarding general overlap: 
 
DSC =
2∗<𝑦𝑡𝑟𝑢𝑒,?̅?𝑝𝑟𝑒𝑑>
<𝑦𝑡𝑟𝑢𝑒,𝑦𝑡𝑟𝑢𝑒>+<?̅?𝑝𝑟𝑒𝑑,?̅?𝑝𝑟𝑒𝑑>
,                                              (7) 
where ?̅?𝑝𝑟𝑒𝑑 is binary prediction using 0.5 as the threshold.  
The Hausdorff distance with 95% confidence interval is the maximum distance of a point in one contour 
to the nearest point of the other contour: 
 
ℎ(𝐴, 𝐵) = max𝑎∈𝐴{min𝑏∈𝐵{𝑑(𝑎, 𝑏)}}                                  (8) 
where a and b are points of sets A and B, respectively, and d(a,b) is Euclidean metric between these 
points[13]. 
Mean Square Error, Mean Absolute Error, Peak Signal to Noise Ratio, and Structural Similarity Index 
were used to quantitatively compare the synthetic MR images created by the generative adversarial 
network to the original MR images obtained from BraTS. 
Mean Squared Error (MSE) is shown in equation 9, with ‘n’ being number of images being compared at 
once. Since MSE depends on intensity scaling, 16-bit images were used with pixel range 0-255. 
 
𝑀𝑆𝐸 =
1
n
⅀{(𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑖𝑚𝑎𝑔𝑒 − 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒𝑑 𝑖𝑚𝑎𝑔𝑒)2}                (9) 
Mean Absolute Error (MAE) is shown in equation 10 and determines the prediction error between the 
actual value and predicted value.  
 
𝑀𝐴𝐸 =
1
n
⅀{abs(original image-generated image)}                              (10) 
Peak Signal to Noise Ratio (PSNR) is shown in equation 11 and is reported in decibels (dB). This 
overcomes the limitation of MSE by scaling the MSE value according to image range, which is done by 
the S2 value in eq 7.  Generally, the higher the PSNR, the better the synthetic image; however, this may 
not always be the case. It is best to compare the PSNR of synthetic image with the same original image.  
𝑃𝑆𝑁𝑅 = −10 ∗ 𝑙𝑜𝑔10 (
𝑀𝑆𝐸
𝑆2
)                                       (11) 
Structural Similarity Index (SSIM) shows the perceived change in structural information as opposed to 
MSE, MAE, and PSNR that show absolute error differences. SSIM assumes pixels close to each other 
possess strong inter-dependency. It is based on luminance, contrast, and structure differences between 
the images and claimed to be the most accurate metric by many studies. 
 
3.0 Results 
3.1 Generative Adversarial Neural Network 
We evaluated the synthetic MR images created by the GAN model qualitatively and quantitatively. 
Several metrics have been used for the quantitative analysis of synthetic versus original images. This 
study employed the commonly used mean square error, peak signal to noise ratio, mean absolute error, 
and structural similarity index. However, these metrics are influenced greatly as there is a major 
difference in tumor location between original and synthetic images as we purposely vary the tumor 
locations in the synthetic images. This creates complications for benchmark comparisons to other 
studies, as they do not change tumor location.  There are additional limitations in these metrics as MSE 
depends on image pixel range (0-255 for this study) and PSNR is best used to compare different 
synthetic images to the same original image, it has less real meaning when compared between different 
datasets.   
Table One: Average reported Mean Square Error (MSE), Mean Absolute Error (MAE), Peak Signal to Noise 
Ratio (PSNR), and Structural Similarity Index (SSIM) for synthetic MR images created by GAN. 
 
 MSE MAE PSNR SSIM 
T1 19.246±0.308 23.375±0.586 43.068±0.443 0.788 ± 0.002 
T1CE 19.249±0.274 22.805±0.583 43.054±0.437 0.789 ± 0.004 
T2 19.246±0.290 23.391±0.400 43.102±0.45 0.784 ± 0.003 
Flair 18.930±0.40 24.119±1.48 43.126±0.46 0.794 ± 0.005 
 Figure 2: Synthetic MRI compared with patient MRI images (none manipulation). A1-A4: synthetic T2, A5-
A8: patient T2; B1-B4: synthetic Flair, B5-B8: patient Flair; C1-C4: synthetic T1, C5-C8: patient T1; D1-D4: 
synthetic T1CE, D5-D8: patient T1CE. 
In Figure 2, the difference between the synthetic image and the patient's actual image is shown in the 
image A3 vs. A7, specifically the tumor in the right frontal lobe (lower left on the image). The signal in the 
core of the tumor has increased T2 signal (brighter) compared with the surrounding edema. The geometric 
aspects of the tumor are preserved, but some of the relative signal intensities are distorted. Images A4 
and A8 show signal from edema (fluid in brain). Image A4 has a wide range of contrast between areas of 
edema, whereas image A8 just delineates the extent of the edema with a sharp drop-off at the edges 
where that drop-off isn't physiologically that sharp. Images B5-B8 have some additional circumferential 
artifact. The extent of the edema on B7 vs B3 is also different. Synthetic quality for images C1-C4 (T1) are 
very good. T1 contrast images in D5-D8 are also geometrically good, although the area of decreased T1 
signal surrounding the tumor in D3 seems to be less distinct on D7. In summary, the synthetic images 
seem stronger for delineation of structural boundaries but struggle more when gradient is significant (e.g. 
edema signal in T2 modalities). 
In addition to these quantitative metrics, qualitative analysis for the generated MR images was assessed 
by a physician. To do this, a subset of 9 real images and 10 generated images flair, T1, T1CE, and T2 MR 
images were compared. The physician was presented with each of these 19 MR images and first judged 
if the MR image was real or synthetic, gave a score, and provided a comment. Ideally the real and 
synthetic images would be completely indistinguishable from each other, and this would be reflected by 
a 50 percent misclassification rate of the images. As shown in table three, Flair, T1CE, and T2 MR images 
were misclassified 26.3 percent of the time, while T1 was incorrectly identified as original or synthetic 
10.5 percent of the time. This lower score was due to slight streaking being visible on coronal and 
sagittal views for some of the images. 
In addition to these quantitative metrics, qualitative analysis for the generated MR images was assessed 
by a physician. To do this, a subset of 9 real images and 10 generated images flair, T1, T1CE, and T2 MR 
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images were compared. The physician was presented with each of these 19 MR images and first judged 
if the MR image was real or synthetic, gave a score, and provided a comment. Ideally the real and 
synthetic images would be completely indistinguishable from each other, and this would be reflected by 
a 50 percent misclassification rate of the images. As shown in table three, Flair, T1CE, and T2 MR images 
were misclassified 26.3 percent of the time, while T1 was incorrectly identified as original or synthetic 
10.5 percent of the time. This lower score was due to slight streaking being visible on coronal and 
sagittal views for some of the images. 
It should be noted that the 210 patients obtained from the BraTS competition ranged over many years. 
Since image quality has improved over these years, the newer images will always have better image 
quality than images generated from lower quality images from years before. Since all images were used 
in the generative adversarial network, the best this generative adversarial network could create would 
be the average of original image quality. 
Table Two: Physician review of subset of synthetic and original images. Percent misjudged shows the 
amount judged as original when it was synthetic and vice versa.  
 
Modality % Misclassified 
Flair 26.3 
T1 10.5 
T1CE 26.3 
T2 26.3 
 
3.2 U-Net Independent Validation Results 
Table Three: Validation Results for U-Nets trained by BraTS MRI and differing subsets of synthetic MRI. 
Underlined values show highest contour metric value. Bolded values indicate contour metric value from 
adding generated MRI greater than using original BraTS data only, while italics indicates the opposite.  
Data Brats 
Brats +1/4 
GAN 
Brats + 1/2 
GAN 
Brats + 3/4 
GAN 
Brats + All 
GAN 
DSC 
ET 0.559 0.506 0.607 0.520 0.607 
WT 0.818 0.789 0.817 0.841 0.828 
TC 0.648 0.638 0.701 0.664 0.683 
Sens. 
ET 0.704 0.795 0.843 0.782 0.621 
WT 0.887 0.899 0.887 0.829 0.796 
TC 0.662 0.740 0.751 0.769 0.648 
Spec. 
ET 0.985 0.985 0.989 0.985 0.990 
WT 0.987 0.979 0.987 0.994 0.994 
TC 0.992 0.990 0.994 0.991 0.995 
HD (mm) 
ET 11.8 16.2 11.2 13.7 8.5 
WT 17.0 23.1 17.0 11.4 11.7 
TC 17.4 22.2 17.0 16.8 13.4 
 
Though we did not observe a strong correlation between the improvement of values of the metrics for 
each structure and amount of synthetic data added, there is a linear relationship between the amount 
of synthetic data added and the number of best overall validation metric value (underlined and bolded 
values). Adding a randomized quarter synthetic subset reports best overall sensitivity for WT, half 
synthetic subset gives best overall metrics in three categories, three-quarters shows best overall metrics 
in four areas and adding all synthetic data to double the training dataset size gives best overall metrics 
in 6 areas.  
Training using all real images combine with half the synthetic images resulted in highest TC DSC value, 
while ET DSC value performed similarly to the model that used all synthetic images during training. This 
deserves a closer look as it seems to combat the hypothesis that the more synthetic images used, the 
better the model performs. However, the HD values, a metric some consider just as valuable as DSC, for 
ET/TC are much worse when using half the synthetic images than when training using all of them. This 
similarity in DSC and discrepancy in HD could come from using soft dice as the loss function. 
The highest WT metrics (DSC, specificity, and HD) resulted from training on all real images and a three-
quarter subset of the synthetic images. If only the WT requires segmentation, this model should be used 
although these values are comparable with validation results when using all synthetic images. 
The synthetic MR images generated by the generative adversarial network showed increased 
performance in HD and DSC when used in totality during training. The difference in sensitivity and 
specificity can be explained by differing size of predicted contours.  
 
4.0 Discussion 
4.1 GAN Benefits 
It has been reported in multiple studies that creating synthetic images using a generative adversarial 
network increases delineation accuracy.  [17]This study investigated how the amount of GAN MR images 
included during the training process affects the U-Net’s ability to accurately delineate the specified 
areas. Multiple U-Nets were trained using just BraTS data, BraTS and a randomized set of quarter, half, 
three quarters, and all GAN created images. To ensure similar level of quality images were used for all 
subgroups, the quarter randomized subset is included in the half synthetic MR image randomized 
subset, and the half synthetic MR image randomized subset is included in the three-quarter randomized 
subset. Obviously, all subsets were included in the total synthetic MR images dataset.  
As expected, training on equal parts original real MR images and synthetic MR images increased 
validation results in most every metric over using real data only. Although, the WT contour metrics are 
not as high as using only three-quarters of the generated images, the increase in enhanced and tumor 
core metric should be noted. It can be observed that using GAN data combined with the original MR 
images from BraTS improves the results for DSC, specificity, and 95% CI HD. However, the sensitivity 
results decreased. We believe that the increased specificity and decreased sensitivity indicates the 
predicted validation contours created from the U-Net trained on both real and synthetic data differs in 
size from the ones trained from BraTS data only.  
 
4.2 GAN Challenges 
As stated in section 3.2 not all synthetic images possess the same quality. This could play a part in why 
adding only a randomized subset of a quarter of the generated images increased contour sensitivity but 
decreased DSC, specificity, and HD. Despite this studies effort, there is a possibility that the lack of 
obvious linearity between number of synthetic images used during training and validation results comes 
from the variation of image quality of synthetic MR images induced from the original image dataset. 
Future work includes training four U-Nets for the quarter subset and two for the half subset and taking 
the average results.   
This lack of linearity shows it can be possible to achieve better validation results for certain contours 
without using all the synthetic or original MR images. To achieve the best results, it needs further 
investigation to understand the impact of the quality and distribution of the training data on the model 
performance. 
 
4.3 INDIVIDUAL CASES 
It is necessary to outline the best and worst cases to assess the model performance. To do this the two 
best performing and worst performing individual cases are presented. Figures 3-6 show whole tumor 
only for ease of viewing.  
   
Figure 3: Case One (Improved). Flair MRI with contour from: both real and synthetic MRI (left) real MRI 
only (Right) DSC of ET/WT/TC was improved from 0.73/ 0.21/0.79 to 0.85/0.67/0.87. Blue is WT. 
 
   
Figure 4: Case Two (Improved). Low-grade Glioma. Flair MRI with contour from: both real and synthetic 
MRI (left) real MRI only (Right) DSC was improved from 0/0.49/0.26 to 0/0.88/0.57.  Blue is WT. 
 
   
Figure 5: Case One (Worsened). Flair MRI with contour from: both real and synthetic MRI (left) real MRI 
only (Right) DSC of ET/WT/TC changed from 0.58/0.76/0.70 to 0.75/0.58/0.76. Blue is WT. 
 
 
       
Figure 6: Case Two (Worsened). Low-Grade Glioma.  Flair MRI with contour from: both real and 
synthetic MRI (left) real MRI only (Right) DSC of ET/WT/TC  showed a decrease from 0.005/0.86/0.06 to 
0.002/0.59/0.008. Blue is WT. 
We have observed encouraging improvement of the segmentation accuracy for high grade glioma cases 
when the lesion was centrally and radially located. However, the challenge still exists in the low-grade 
glioma considering the difficulty to define the boundary. Location also plays a role in discerning whether 
the contouring accuracy would increase or decrease as the improved low-grade glioma was centrally 
located, while the one that showed worse results was located towards the edge of the brain.  
 
5.0 Conclusion 
We were able to generate high quality synthetic Flair, T2, T1, and T1CE MR images using the GAN and 
had a thorough evaluation of the images quantitatively and qualitatively.  The increased dataset showed 
promising results to improve the U-Net segmentation performance for overall DSC and HD. Such data 
augmentation strategy has the potential to address the small labeled data challenges in the medical 
image segmentation.   
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